Skip to the content

Parallel trade of pharmaceutical products: the ECJ finally speaks— Comment on GlaxoSmithKline

Petrucci, Carlo 2010, 'Parallel trade of pharmaceutical products: the ECJ finally speaks— Comment on GlaxoSmithKline' , European Law Review (2) , pp. 275-286.

[img] PDF - Published Version
Restricted to Repository staff only

Download (314kB) | Request a copy


    This article reviews the ECJ’s judgment in GlaxoSmithKline that overturned some important findings of the CFI’s decision. It criticises the longstanding problematic distinction between anti-competitive object and effect and, in particular, whether distribution agreements that limit parallel trade fit into the category of agreement having an anti-competitive object. Given that the ECJ’s decision reasserted a multi- goal approach to EU competition law, it is argued that the judgment leaves some issues unresolved. Similarly, the issues of the effects of price regulation and research and development (R&D) funding have not been dealt with adequately.

    Item Type: Article
    Themes: Subjects outside of the University Themes
    Schools: Colleges and Schools > College of Business & Law > Salford Business School > International Strategy People Management & Salford Law
    Journal or Publication Title: European Law Review
    Publisher: Sweet & Maxwell
    Refereed: Yes
    ISSN: 0307-5400
    Depositing User: Mr Carlo Petrucci
    Date Deposited: 15 Nov 2011 10:32
    Last Modified: 29 Oct 2013 13:54

    Actions (login required)

    Edit record (repository staff only)

    No Altmetrics available

    Downloads per month over past year

    View more statistics